Skip to content

BOONE CAPITAL MANAGEMENT LLC

Follow

13F filer, CIK 1882053, ATLANTA, GA

BOONE CAPITAL MANAGEMENT LLC reported $376,702,434 across 16 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 81.08% of the portfolio.

Accepted , ingested 13F-HR 0001214659-26-014343

Period
2026-09-30
Reported value
$377M
Holdings
16
Top 10 weight
81.08%
New
5
Sold out
5

Largest buys vs the previous quarter

SecurityShares changeApprox. value
AVTRnew+1,838,972$27.7M
LHnew+87,551$27M
EHCnew+205,838$25M
WAYnew+508,649$12.9M
BMRNadded+88,779$5.33M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
IONSexited-519,977-$41.2M
GLUEexited-615,287-$14.9M
KODexited-378,010-$14.7M
TNGXexited-455,605-$14.2M
KYMRexited-113,173-$13M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001214659-26-014343, largest first. % of portfolio is the value over $376,702,434, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 327,279 shares; 2025Q2: 447,449 shares; 2025Q3: 328,546 shares; 2025Q4: 411,880 shares; 2026Q1: 547,871 shares; 2026Q2: 583,219 shares; 2026Q3: 671,998 shares 671,998$40.3M10.7%+88,779Timeline
TFXTELEFLEX INCORPORATEDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 278,792 shares; 2026Q2: 387,388 shares; 2026Q3: 288,899 shares 288,899$36.1M9.59%-98,489Timeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 581,843 shares; 2025Q1: 603,318 shares; 2025Q2: 641,448 shares; 2025Q3: 535,732 shares; 2025Q4: 421,236 shares; 2026Q1: 421,236 shares; 2026Q2: 415,641 shares; 2026Q3: 415,641 shares 415,641$35.5M9.43%0Timeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 58,112 shares; 2025Q3: 58,112 shares; 2025Q4: 61,762 shares; 2026Q1: 79,226 shares; 2026Q2: 88,687 shares; 2026Q3: 88,687 shares 88,687$32.6M8.64%0Timeline
CITHE CIGNA GROUPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 85,861 shares; 2025Q1: 70,859 shares; 2025Q2: 35,600 shares; 2025Q3: 82,972 shares; 2025Q4: 96,453 shares; 2026Q1: 137,522 shares; 2026Q2: 159,290 shares; 2026Q3: 112,268 shares 112,268$30.5M8.1%-47,022Timeline
GRDNGUARDIAN PHARMACY SVCS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 631,193 shares; 2026Q2: 711,939 shares; 2026Q3: 725,061 shares 725,061$29.6M7.85%+13,122Timeline
AVTRAVANTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,694,482 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,838,972 shares 1,838,972$27.7M7.35%newTimeline
LHLABCORP HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 87,551 shares 87,551$27M7.16%newTimeline
EHCENCOMPASS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 205,838 shares 205,838$25M6.64%newTimeline
VSTSVESTIS CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,900,140 shares; 2026Q3: 1,583,652 shares 1,583,652$21.2M5.62%-316,488Timeline
PNTGPENNANT GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 641,255 shares; 2025Q1: 719,137 shares; 2025Q2: 649,022 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 515,818 shares; 2026Q3: 525,916 shares 525,916$20.5M5.44%+10,098Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 460,282 shares; 2025Q4: 184,963 shares; 2026Q1: 228,829 shares; 2026Q2: 339,720 shares; 2026Q3: 277,433 shares 277,433$18.3M4.85%-62,287Timeline
WAYWAYSTAR HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 508,649 shares 508,649$12.9M3.42%newTimeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 704,442 shares; 2026Q3: 690,814 shares 690,814$10.6M2.81%-13,628Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 179,495 shares 179,495$4.88M1.3%newTimeline
ANLADLAI NORTYE GROUP LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 258,390 shares; 2026Q3: 258,390 shares 258,390$4.13M1.1%0Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
IONSIONIS PHARMACEUTICALS INC519,977$41.2Mshares
GLUEMONTE ROSA THERAPEUTICS INC615,287$14.9Mshares
KODKODIAK SCIENCES INC378,010$14.7Mshares
TNGXTANGO THERAPEUTICS INC455,605$14.2Mshares
KYMRKYMERA THERAPEUTICS INC113,173$13Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001214659-26-014343 base2026-11-16